Product image of Iomeron (Iomeprol) supplied by GNH India

Iomeron

Active Ingredient:
Iomeprol
Origin:
EU

Iomeron (Iomeprol)

Iomeprol, the active ingredient in Iomeron, is an iodinated contrast media presented as a solution for injection for intraarterial, intraarticular and intravenous use. It enhances radiographic visualization during imaging procedures such as angiography, arthrography and computed tomography, allowing clinicians to assess vascular and joint structures in adult, pediatric and neonatal patients, thereby improving diagnostic confidence.

GNH India supplies Iomeron as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing for diagnostic imaging programs globally.

Manufacturer / TM Owner

Bracco Imaging S.P.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Iomeron is an iodinated contrast agent used in radiographic procedures that require enhanced X‑ray attenuation.

  • Angiography: provides clear delineation of blood vessels for diagnostic and interventional procedures.
  • Arthrography: improves visualization of joint spaces to assess cartilage, ligaments and intra‑articular pathology.
  • Computed tomography (CT) imaging: enhances contrast between tissues, aiding detection of lesions and vascular structures.

How It Works

  • Iomeprol contains a high density of iodine atoms that absorb X‑ray photons. When administered intravenously, intra‑arterially or intra‑articularly, the iodine molecules increase the attenuation of X‑ray beams in the vascular or joint compartments, creating a temporary difference in radiodensity between the contrast‑filled structures and surrounding tissues. This contrast enhancement allows imaging systems to generate high‑resolution detailed images of anatomical details.

Side Effects

Iomeron may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects

  • Warmth or flushing sensation at injection site.
  • Metallic taste in the mouth.
  • Nausea or vomiting.
  • Mild urticaria or itching.
  • Headache.
  • Transient hypotension.

Serious or Rare Side Effects

  • Severe allergic reaction or anaphylaxis.
  • Acute kidney injury, especially in patients with pre‑existing renal impairment.
  • Cardiovascular collapse or arrhythmia.
  • Pulmonary edema.
  • Seizures.
  • Death (rare).

Precautions & Warnings

Prior to using Iomeron, clinicians should observe several safety considerations to minimize risk.

  • Assess renal function: evaluate serum creatinine and eGFR before administration.
  • Screen for iodine or contrast media allergy: obtain detailed allergy history.
  • Monitor thyroid status: avoid use in patients with uncontrolled hyperthyroidism.
  • Use caution in pregnancy: limited data, weigh diagnostic benefit against potential fetal exposure.
  • Adjust metformin therapy in patients with renal impairment: consider temporary discontinuation.
  • Store below 25°C: keep in original container, protect from light and moisture.

Avoid Interactions

Iomeron can interact with certain medications and substances, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid)

  • Concurrent use of other iodinated contrast agents: may increase iodine load.
  • High‑dose iodine supplements or thyroid hormone therapy: can exacerbate thyroid dysfunction.
  • Metformin in patients with renal impairment: risk of lactic acidosis.

Moderate Interactions (Monitor Closely)

  • Beta‑blockers: may mask early signs of hypersensitivity.
  • ACE inhibitors or ARBs: can potentiate hypotensive effects.
  • Diuretics: may affect renal clearance of contrast.
  • NSAIDs: increase risk of renal injury when combined with contrast.
  • Calcium channel blockers: monitor blood pressure changes.

Frequently Asked Questions

Iomeron is an iodinated contrast media used to enhance X‑ray based imaging such as angiography, arthrography and CT scans, helping visualize blood vessels, joints and internal structures.

Iomeprol contains iodine atoms that absorb X‑ray photons, increasing attenuation of the X‑ray beam in the area where it is administered. This creates a temporary difference in radiodensity between the contrast‑filled region and surrounding tissues, producing clearer images.

The dose of Iomeron is determined by the prescribing physician based on the specific imaging study, patient weight, renal function and the required level of contrast. No fixed regimen is provided in public literature; the prescriber sets the appropriate volume and concentration.

Safety data for Iomeron in pregnancy and lactation are limited. It is classified as a category where the potential benefits must be weighed against possible risks to the fetus or infant. Use only if clearly needed and after consulting a qualified healthcare professional.

To place an order, submit an enquiry on the Iomeron product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Iomeron (iomeprol) is a non‑ionic, low‑osmolality iodinated contrast medium, offering high X‑ray attenuation with a lower incidence of discomfort compared with older high‑osmolality agents. Its safety profile is comparable to other modern low‑osmolality agents, but selection depends on specific clinical needs and institutional protocols.

Iomeron should be stored below 25 °C in its original packaging, protected from light, moisture and freezing. Before use, inspect the solution for particulate matter or discoloration and allow it to reach room temperature if refrigerated.

Iomeron is supplied as a sterile solution for injection and is administered intravenously, intra‑arterially or intra‑articularly by a qualified healthcare professional. The injection rate and volume are adjusted according to the imaging protocol and patient characteristics.

The most serious risks include severe allergic reactions such as anaphylaxis, acute kidney injury especially in patients with pre‑existing renal impairment, and cardiovascular events like hypotension or arrhythmia. Immediate medical attention is required if any of these occur.

Iomeron should be avoided in patients with a known hypersensitivity to iodinated contrast media, uncontrolled hyperthyroidism, severe renal insufficiency, or in those for whom the diagnostic benefit does not outweigh the potential risks. Clinical judgment is essential.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Iomeprol

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT